IQVIA Holdings Inc.
IQVHealthcareNASDAQDiagnostics & Research · Last scanned Oct 24, 2026
Scan Results
Daily timeframePart of the healthcare sector, IQVIA Holdings Inc. (IQV) is listed under Diagnostics & Research. With a market capitalization of $45.98B, it sits in large-cap territory. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
Market Cap
$45.98B
Beta
1.17
P/E (TTM)
34.70
P/E (Fwd)
19.41
EPS (TTM)
$8.05
EPS (Fwd)
$14.39
ROE
22.8%
ROA
5.1%
Cash
$2.08B
Total Debt
$16.25B
Free CF
$2.15B
52W Change
26.7%
Annual Financials
Cash vs Debt
Where IQV stands vs its 150-day and 200-day moving averages
As of the September 8, 2026 close, IQV finished 39.11% above its 150-day moving average ($192.49) and 32.63% above its 200-day moving average ($201.89). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is IQV overbought or oversold?
At the September 8, 2026 close, IQV's RSI(14) was 78.6, in overbought territory (above 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, IQV has $2.08B in cash with $16.25B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $2.15B, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 22.8%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 5.1% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $14.41B to $16.31B.
IQVIA Holdings Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. No single metric tells the full story. Reviewing IQV's risk profile alongside its fundamentals and technical indicators provides a more complete picture.